JNJ

186.91

+0.65%↑

ABT

126.16

+1.63%↑

TMO

562.37

-0.22%↓

ISRG

537.82

-0.35%↓

DHR

212.32

-0.15%↓

JNJ

186.91

+0.65%↑

ABT

126.16

+1.63%↑

TMO

562.37

-0.22%↓

ISRG

537.82

-0.35%↓

DHR

212.32

-0.15%↓

JNJ

186.91

+0.65%↑

ABT

126.16

+1.63%↑

TMO

562.37

-0.22%↓

ISRG

537.82

-0.35%↓

DHR

212.32

-0.15%↓

JNJ

186.91

+0.65%↑

ABT

126.16

+1.63%↑

TMO

562.37

-0.22%↓

ISRG

537.82

-0.35%↓

DHR

212.32

-0.15%↓

JNJ

186.91

+0.65%↑

ABT

126.16

+1.63%↑

TMO

562.37

-0.22%↓

ISRG

537.82

-0.35%↓

DHR

212.32

-0.15%↓

Kodu・Aktsiate loetelu・Establishment Labs Holdings Inc

Establishment Labs Holdings Inc

Avatud

SektorTervishoid

56.28 18.11

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

46.9

Max

54.47

Põhinäitajad
By Trading Economics
Sissetulek	4.1M -17M
Müük	9.9M 51M
Kasumimarginaal	-32.345
Töötajad	1,056
EBITDA	9.9M -7M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+19.94% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	5. nov 2025

Turustatistika
By TradingEconomics
Turukapital	148M 1.4B
Eelmine avamishind	38.17
Eelmine sulgemishind	56.28

Uudiste sentiment

By Acuity

100%

356 / 373 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bullish Evidence

30.5 / N/A Toetus ja vastupanu

Establishment Labs Holdings Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

4. nov 2025, 23:57 UTC

Tulu

Naver's Third-Quarter Earnings Rose on AI Push

4. nov 2025, 23:10 UTC

Omandamised, ülevõtmised, äriostud

Kennedy-Wilson Gets Acquisition Proposal From CEO, Fairfax Financial

4. nov 2025, 23:48 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

4. nov 2025, 23:48 UTC

Market Talk

Nikkei May Fall After U.S. Tech Stock Weakness -- Market Talk

4. nov 2025, 23:37 UTC

Market Talk

Gold Edges Higher on Possible Technical Recovery -- Market Talk

4. nov 2025, 23:30 UTC

Tulu

Itau Unibanco 3Q Net BRL33.7B >ITUB

4. nov 2025, 23:25 UTC

Tulu

Naver 3Q Net Profit Beat FactSet-Compiled Consensus

4. nov 2025, 23:25 UTC

Tulu

Naver 3Q Net KRW734.70B Vs. Net KRW530.10B >035420.SE

4. nov 2025, 23:24 UTC

Tulu

Naver 3Q Oper Pft KRW570.60B Vs. Pft KRW525.30B >035420.SE

4. nov 2025, 23:23 UTC

Tulu

Naver 3Q Rev KRW3.138T Vs. KRW2.716T >035420.SE

4. nov 2025, 23:06 UTC

Tulu

Review & Preview: Tech Check -- Barrons.com

4. nov 2025, 22:52 UTC

Tulu

AMD Reports Sharply Higher Profits, Sales -- 3rd Update

4. nov 2025, 22:33 UTC

Tulu

AMD Beats Earnings. The Stock Still Slides. -- Barrons.com

4. nov 2025, 22:29 UTC

Tulu

Ashland 4Q Adj EPS $1.08 >ASH

4. nov 2025, 22:29 UTC

Tulu

Ashland Sees FY26 Adjusted EPS Up More Than Double Digits >ASH

4. nov 2025, 22:28 UTC

Tulu

Ashland Sees FY26 Sales $1.84B-$1.91B >ASH

4. nov 2025, 22:27 UTC

Tulu

Ashland 4Q Cont Ops EPS 73c >ASH

4. nov 2025, 22:27 UTC

Tulu

Ashland 4Q EPS 71c >ASH

4. nov 2025, 22:27 UTC

Tulu

Ashland 4Q Sales $478M >ASH

4. nov 2025, 22:23 UTC

Tulu

Ovintiv 3Q EPS 57c >OVV

4. nov 2025, 22:19 UTC

Market Talk

Canada Budget: Snap Election Talk Might Cool -- Market Talk

4. nov 2025, 22:16 UTC

Tulu

AMD Reports Sharply Higher Profits, Sales -- 2nd Update

4. nov 2025, 22:14 UTC

Omandamised, ülevõtmised, äriostud

Kennedy-Wilson Board Forms Special Committee to Evaluate Proposal

4. nov 2025, 22:13 UTC

Omandamised, ülevõtmised, äriostud

Consortium: Not Interested in Selling Kennedy-Wilson Shares to Another Party

4. nov 2025, 22:13 UTC

Omandamised, ülevõtmised, äriostud

Consortium: Able to Finance a Deal With Available Liquidity

4. nov 2025, 22:12 UTC

Omandamised, ülevõtmised, äriostud

Consortium Owns About 31% of Kennedy-Wilson Stock on As-Converted Basis

4. nov 2025, 22:11 UTC

Tulu

Private-Credit Earnings Ease Investor Concern Over Market's Health -- Update

4. nov 2025, 22:11 UTC

Omandamised, ülevõtmised, äriostud

Kennedy-Wilson Gets Proposal From CEO William McMorrow and Fairfax Financial Holdings

4. nov 2025, 22:10 UTC

Omandamised, ülevõtmised, äriostud

Pfizer, Novo Nordisk Escalate Bidding War for Weight-Loss Drug Startup -- 2nd Update

4. nov 2025, 22:07 UTC

Tulu

Kinross Gold Raises Dividend to $0.035 >K.T

Võrdlus sarnastega

Hinnamuutus

Establishment Labs Holdings Inc Prognoos

Hinnasiht

By TipRanks

19.94% tõus

12 kuu keskmine prognoos

Keskmine 57.33 USD 19.94%

Kõrge 70 USD

Madal 43 USD

Põhineb 6 Wall Streeti analüütiku instrumendi Establishment Labs Holdings Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

6 ratings

Osta

Hoia

Müü

Põhineb 6 analüütiku instrumendi Establishment Labs Holdings Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

30.5 / N/AToetus ja vastupanu

Bullish events outweigh bearish events.

Bearish events outweigh bullish events.

All events are bearish.

Sentiment

By Acuity

356 / 373 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Establishment Labs Holdings Inc

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.